カジノ シークレット 出 金 条件uire Plant Growth Regulator Business from Kyowa Hakko Bio

Aug. 4, 2017

カジノ シークレット 出 金 条件 has reached an agreement with Kyowa Hakko Bio Co., Ltd. to acquire Kyowa Hakko Bio’s plant growth regulator business.

カジノ シークレット 出 金 条件s are crop enhancement products that help improve crop quality and yields by promoting or controlling crop growth and development, such as making fruit larger or promoting flowering. カジノ シークレット 出 金 条件s are widely used around the world.

As a pioneer in Japan’s カジノ シークレット 出 金 条件 market, Kyowa Hakko Bio has been expanding its business in this field since 1958, when it began selling "Gibberellin Kyowa" tablet. It sells the gibberellin product "Gibberellin Kyowa" and the forchlorfenuron product "Fulmet", which have such effects as increasing the size of pears and grapes and making grapes seedless.

Amid a wave of large-scale consolidation and restructuring of the world’s crop protection products companies, カジノ シークレット 出 金 条件 is constantly expanding its business in this field, leveraging its versatile strengths, including advanced capabilities of developing new crop protection & enhancement products, creation of unique businesses such as biorationals, global sales networking, and alliances with major manufacturers in the world. Among others, in the specialties areas, such as biorationals where the market is expected to continue growing at a high rate, カジノ シークレット 出 金 条件 has been aggressive in recent years in carrying out M&A transactions and enhancing its R&D capabilities. The agreed transaction of business acquisition allows カジノ シークレット 出 金 条件 to further strengthen its business in these areas by combining Kyowa Hakko Bio’s high-quality products, excellent specialized knowledge, and wide brand recognition in Japan’s plant growth regulator market with the technologies and other expertise カジノ シークレット 出 金 条件 has cultivated or refined over the years.

The acquisition of the plant growth regulator business is another important step for カジノ シークレット 出 金 条件 to expand its worldwide product portfolio further and contribute to improving agricultural crop productivity in the world.

Overview of Kyowa Hakko Bio

Company name	Kyowa Hakko Bio Co., Ltd.
Date established	October 1, 2008
Capital	10 billion yen (100% subsidiary of Kyowa Hakko Kirin Co., Ltd.)
Sales	84 billion yen (Consolidated, as of December 2016)
Representative	Chikakuni Kotani, President and Chief Executive Officer
Business description	Manufacture and sale of pharmaceutical ingredients, amino acids, health foods, and カジノ シークレット 出 金 条件s

Contact

Corporate Communications Dept.
27-1, Shinkawa 2-chome, Chuo-ku, Tokyo, 104-8260, Japan
TEL: +81-3-5543-5102 FAX: +81-3-5543-5901